作者
Amir R Afshari, Mohammad Jalili-Nik, Farzaneh Abbasinezhad-Moud, Hossein Javid, Mohammad Karimi, Hamid Mollazadeh, Tannaz Jamialahmadi, Thozhukat Sathyapalan, Amirhossein Sahebkar
发表日期
2021/12/1
来源
Current medicinal chemistry
卷号
28
期号
39
页码范围
8116-8138
出版商
Bentham Science Publishers
简介
Glioblastoma Multiforme (GBM) is a poorly curable brain tumor because of its extremely invasive nature. Curcuminoids, as potential phytochemicals extracted from Curcuma Longa L., have been documented for their chemopreventive and antitumor activities against several types of malignancies. These compounds exert these effects via modulation of multiple signaling pathways and molecular targets at different stages of tumor progression, proliferation, and metastasis. In experimental studies, curcuminoids have demonstrated promising therapeutic benefits to overcome GBM. Curcuminoids have been shown to exert their anti-GBM effects through regulation of angiogenesis, apoptosis, autophagy, metastasis, invasion, as well as potential molecular targets, including receptor tyrosine kinases, Sonic Hedgehog, and NF-ΚB. This study reviews the observations regarding the impact of curcumin and its derivatives on …
引用总数
学术搜索中的文章